alfuzosin beta 10 mg retardtabletten
alfuzosin hydrochloride extended release- alfuzosin hydrochloride tablet
camber pharmaceuticals - alfuzosin hydrochloride (unii: 75046a1xtn) (alfuzosin - unii:90347ytw5f) - alfuzosin hydrochloride 10 mg - alfuzosin hydrochloride is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. alfuzosin hydrochloride is not indicated for the treatment of hypertension. alfuzosin hydrochloride is not indicated for use in the pediatric population. alfuzosin hydrochloride is contraindicated for use: - in patients with moderate or severe hepatic impairment (childs-pugh categories b and c), since alfuzosin blood levels are increased in these patients [see use in specific populations (8.7) and clinical pharmacology (12.3)] . - with potent cyp3a4 inhibitors such as ketoconazole, itraconazole, and ritonavir, since alfuzosin blood levels are increased [see drug interactions (7.1) and clinical pharmacology (12.3)] . - in patients with known hypersensitivity, such as urticaria and angioedema, to alfuzosinhydrochloride or any component of alfuzosin hydrochloride tablets [see adverse reactions (6.2)] pregnancy category b. alfuzosin hydrochloride is not indicated for use in women, and there are no studie
alfuzosin aurobindo 10 mg retardtabletten
alfuzosin hydrochloride extended release tablet
avera mckennan hospital - alfuzosin hydrochloride (unii: 75046a1xtn) (alfuzosin - unii:90347ytw5f) - alfuzosin hydrochloride 10 mg
dutasterid/tamsulosinhydrochlorid "g.l. pharma" 0,5+0,4 mg kapsler, hårde
dutasterid/tamsulosinhydrochlorid "polpharma" 0,5+0,4 mg kapsler, h?rde
solifenacinsuccinat/tamsulosinhydrochlorid "aristo" 6+0,4 mg tabletter med modificeret udløsning
solifenacinsuccinat/tamsulosinhydrochlorid "rafarm" 6+0,4 mg tabletter med modificeret udløsning
solifenacinsuccinat/tamsulosinhydrochlorid "heumann" 6+0,4 mg tabletter med modificeret udløsning
solifenacinsuccinat/tamsulosinhydrochlorid "teva" 6+0,4 mg tabletter med modificeret udløsning